Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Antidepressants inhibit cancer growth in mice
Classic antidepressants could help improve modern cancer treatments. They slowed the growth of pancreatic and…
One in five future thyroid cancers linked to excess weight
Avoiding excess weight, especially obesity, should be a priority for thyroid cancer prevention, the first…
Too many firefighters are dying of cancer
They’re our modern-day superheroes — charging into burning buildings without hesitation, rescuing those in peril,…
Cancer costs Australian health services over $6 billion a year: new research
New research by Cancer Council NSW has revealed the cost of cancer to Australia’s health services: the study found that…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.